View this email in your browser Kia ora,Welcome to the first edition of the HealthTech Activator (HTA) Monthly Wrap for 2026. We hope you had a restful summer break and found time to recharge.As we head into the new year, there’s a strong sense of momentum across Aotearoa’s healthtech sector, from
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

View this email in your browser

HealthTech Activator banner


Kia ora,


Welcome to the first edition of the HealthTech Activator (HTA) Monthly Wrap for 2026. We hope you had a restful summer break and found time to recharge.


As we head into the new year, there’s a strong sense of momentum across Aotearoa’s healthtech sector, from major national investments to frontline digital innovation and growing commercial impact from local ventures.


NZ innovation highlights


Building national capability in advanced health technologies

A significant development for the innovation landscape is the establishment of the New Zealand Institute for Advanced Technology (NZIAT). As a new public research organisation, NZIAT has been created to bring researchers, industry, and investors closer together, with a clear focus on translating advanced science into real-world impact.


With board governance that includes biomedical engineer Professor Greg O’Grady and physicist-entrepreneur Cather Simpson, both with strong links to founder-led innovation and commercialisation, the institute signals a more coordinated approach to building national capability.


The HTA is expected to transition into NZIAT, with details on timing, structure, and scope still to be confirmed. In the interim, HTA continues its work supporting healthtech companies to build, validate, and scale.


Learn more about how HealthTech Activator continues to support healthtech founders.


Digital tools supporting clinical workflows

Through HealthX, Te Whatu Ora’s digital innovation programme, AI scribe tools are now being rolled out across public emergency departments following successful pilots in multiple regions. The tools securely capture clinician patient conversations and generate draft clinical notes and referrals for review, significantly reducing documentation time per patient and after shift admin. Early results show improved clinical efficiency, better workflow flow in busy ED settings, and strong clinician uptake, with many staff advocating for wider access as the rollout expands nationally.


Now live: HealthTech Activator’s Digital Health page

See how we support founders to design, validate, and scale digital health solutions aligned with national priorities.


Get in Touch


As always, the HealthTech Activator is here to help your venture build strong foundations, from early market validation through to regulatory readiness and quality management. Contact us to get started.

Upcoming HTA workshops

Build to Scale Series: Now Live


Build to Scale is HTA’s series for founders who are moving from early traction to scalable growth.


This programme is built around four core growth pillars: market validation, clinical validation, reimbursement, and regulatory readiness.


You’ll find expert-led resources, founder insights, and real-world case examples, grounded in the New Zealand context and relevant to global markets.


The first Build to Scale modules, covering market validation and health economics, are now live. Follow the HealthTech Activator on LinkedIn for weekly content updates as the series rolls out.

QMS Corner: ISO 13485 Learning Series


Q3 – Risk & Efficiency Focus

Quarter 3 of the QMS Series is now underway, focusing on strengthening how risk and efficiency are embedded within an ISO 13485–aligned QMS.


This quarter focuses on:

  • Risk management in QMS
  • Lean compliance approaches
  • Compliance as a competitive advantage

Latest Article: 

ISO 13485 and Risk Management: How to Build a Proactive QMS

This article explores how ISO 13485 and ISO 14971 work together in practice, and how manufacturers can embed risk management into their QMS so that risk actively steers decisions across the product lifecycle.


Upcoming webinar:

Driving Quality Forward: Risk and Efficiency Strategies for ISO 13485 Success

24 March 2026, 11am - 12pm, Online


This session will explore how to apply risk-based thinking to build efficient, scalable QMS processes that support both compliance and business outcomes.

REGISTER HERE

Additional Q3 resources, including a quiz and whitepaper, will be released throughout the quarter.

Know Your Customer, Know Your Market

19 February 2026, 9am - 4.30pm, Christchurch


A lack of robust market validation is one of the most common weaknesses of Healthtech businesses searching for investment.


This workshop is aimed at early-stage Healthtech companies, or Healthtech companies that would like to have a fresh look at their market and how they have validated it to date. Led by Dan Hansen, Director of consulting firm Apagie and CEO of AVRT Group, this workshop will utilise Dan’s cross-industry and first-hand experience to give companies the right processes for successfully commercialising and growing their health technology products and services.

REGISTER HERE

Health Economics Workshop

18 March 2026, 9am - 3pm, Auckland


Understand the drivers and processes used to determine economic value and a health system’s willingness to pay for a healthcare product. This highly interactive workshop is intended for decision-makers and organisations wanting to systematically compare technologies, access new markets, and secure reimbursement strategies across several healthcare environments and systems. The workshop is co-produced with Te Tītoki Mataora and led by Abbas Al-Murrani - Managing Director & Founder, Health Economics Consulting NZ.

REGISTER HERE

NZ Sector Events

News

NZ News


Recent developments across NZ health research include mobile optometry services, advances in melanoma treatment, and new brain health research. HTA-associated company TheiaNova has reached a key milestone, dosing its first patient in a first-in-human trial of a regenerative eye drop for keratoconus.

Volunteer optometrist Lynden Mason working with a young patient on the bus (RNZ)

  • 'Celia' the optometry bus hits the road to check Kiwi kids
  • TheiaNova doses first patient in FIH trial on regenerative eye drop for keratoconus
  • NZ scientists hope $1m boost leads to new melanoma treatment
  • The crucial brain health research done in Aotearoa

World News

  • R&D Operations Bottlenecks in Large Life Sciences Organizations: What can MedTech Leaders Do?
  • Regulatory Roundup: global medical device regulatory update
  • The FDA Raised the Bar on MedTech Cybersecurity: Are Companies Ready?

Mā te wā,


HealthTech Activator team

Callaghan Innovation


Was this email forwarded to you? You can subscribe to future emails on the HTA website. For regular updates and insights follow the HealthTech Activator on LinkedIn.

 

Callaghan Innovation; 69 Gracefield Road, Gracefield, Lower Hutt, 5010